2023
Other Research Output
Faed, J. (April, 2023). The 21st century iron renaissance: A new Iron Age has started. Otago Medical School Alumni Association (OMSAA) History of Medicine and Science Talks, Dunedin, New Zealand. Retrieved from https://www.youtube.com/watch?v=PcLz5BkAaL8
2020
Journal - Research Article
Zhang, J., Crimmins, D., Faed, J. M., Flanagan, P., McGhee, C. N. J., & Patel, D. V. (2020). Characteristics of platelet lysate compared to autologous and allogeneic serum eye drops. Translational Vision Science & Technology, 9(4), 24. doi: 10.1167/tvst.9.4.24
2018
Journal - Research Article
Ng, D. P. J., Duffull, S. B., Faed, J. M., Isbister, G. K., & Gulati, A. (2018). An evaluation of a factor Xa-based clotting time test for enoxaparin: A proof-of-concept study. Clinical & Applied Thrombosis/Hemostasis, 24(4), 669-676. doi: 10.1177/1076029617711802
Journal - Research Other
Kerr, N., Kerr, J., Faed, J. M., & Krysa, J. (2018). Spontaneous intracerebral haemorrhage: A rare complication of aortic aneurysm endoleak. BMJ Case Reports. doi: 10.1136/bcr-2018-225249
2017
Journal - Research Article
Nelson, V. J., Dinnunhan, M. F. K., Turner, P. R., Faed, J. M., & Cabral, J. D. (2017). A chitosan/dextran-based hydrogel as a delivery vehicle of human bone-marrow derived mesenchymal stem cells. Biomedical Materials, 12(3), 035012. doi: 10.1088/1748-605X/aa70f2
Muhsin-Sharafaldine, M.-R., Kennedy, B. R., Saunderson, S. C., Buchanan, C. R., Dunn, A. C., Faed, J. M., & McLellan, A. D. (2017). Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles. Biochimica et Biophysica Acta: General Subjects, 1861(2), 286-295. doi: 10.1016/j.bbagen.2016.11.020
2016
Journal - Research Article
Anderson, K. R., & Faed, J. M. (2016). Evaluation of particulate material in stored units of New Zealand re-suspended red cells. New Zealand Journal of Medical Laboratory Science, 70(3), 106-109.
Goldman, M., Magnussen, K., Gorlin, J., Lozano, M., Speedy, J., Keller, A., … Faed, J., … Klein, H. G. (2016). International Forum regarding practices related to donor haemoglobin and iron. Vox Sanguinis, 111(4), 449-455. doi: 10.1111/vox.12431
Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D. (2016). Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget, 7(35), 56279-56294. doi: 10.18632/oncotarget.10783
Conference Contribution - Verbal presentation and other Conference outputs
Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D. (2016, August-September). Procoagulant and immunogenic properties of tumour exosomes, microvesicles and apoptotic vesicles. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
Cabral, J. D., Nelson, V., Faed, J., Hanton, L., & Moratti, S. (2016, August-September). Development and characterization of chitosan/dextran-based hydrogels for adult stem cell delivery. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
2015
Journal - Research Article
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2015). Application of adaptive DP-optimality to design a pilot study for a clotting time test for enoxaparin. Pharmaceutical Research, 32(10), 3391-3402. doi: 10.1007/s11095-015-1715-1
Wong, W.-W., MacKenzie, A. D., Nelson, V. J., Faed, J. M., & Turner, P. R. (2015). Octanoate in human albumin preparations is detrimental to mesenchymal stromal cell culture. Stem Cells International, 2015, 192576. doi: 10.1155/2015/192576
Aung, N. N., Kennedy, H., Faed, J. M., & Brennan, S. O. (2015). Novel heterozygous Bbeta (c.1311T>A) mutation (Fibrinogen St Kilda) associated with recurrent pregnancy loss. Pathology, 47(6), 583-585. doi: 10.1097/pat.0000000000000307
Conference Contribution - Poster Presentation (not in published proceedings)
Muhsin, M.-R., Dunn, A., Saunderson, S., Faed, J., & McLellan, A. (2015, October). The effects of tumour vesicles on cancer metastasis. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.
2014
Journal - Research Article
Brennan, S. O., Mangos, H., & Faed, J. M. (2014). Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative y211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia. Thrombosis & Haemostasis, 111(4), 679-684. doi: 10.1160/TH13-08-0657
2013
Conference Contribution - Published proceedings: Abstract
Muhsin, M.-R., Saunderson, S., Black, L., Dunn, A., Faed, J., & McLellan, A. (2013). The effects of tumour vesicles on cancer progression. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 137-138). Retrieved from http://www.asi2013.org/
Faed, J. M. (2013). A systems approach to a Massive Transfusion Protocol (MTP). Transfusion, 53(Suppl. S2), (pp. 196A). doi: 10.1111/trf.12401
Yap, A., Faed, J., & Chiruka, S. (2013). An audit of outcomes for patients treated with Prothrombinex-VF. New Zealand Medical Journal, 126(1374). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Gunn, K., Faed, J., & Warner, M. (2013, November). Managing systems not problems. Verbal presentation at the New Zealand Anaesthesia (NZA) Annual Scientific Meeting, Dunedin, New Zealand.
2012
Journal - Research Article
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin. Pharmaceutical Research, 29(1), 225-235. doi: 10.1007/s11095-011-0537-z
Journal - Research Other
Duffull, S. B., Wright, D. F. B., Al-Sallami, H. S., Zufferey, P. J., & Faed, J. M. (2012). Dabigatran: Rational dose individualisation and monitoring guidance is needed. New Zealand Medical Journal, 125(1357). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Evaluation of a clotting time test for enoxaparin: A pilot study. Proceedings of the Medical Sciences Congress (MedSci). (pp. 22). Retrieved from http://www.medscinz.co.nz/QRW2012%20MedSci%20Abstracts.pdf
Harper, P., Aung, N. N., Eaddy, N., Faed, J., May, S., Merriman, E., … Young, L. (2012). Dabigatran should be used with caution in the frail elderly: Lessons from New Zealand. American Journal of Hematology, 87(Suppl. 1), (pp. S175-S176). doi: 10.1002/ajh.23168
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Adaptive PD-optimal design of a pilot study for a clotting time test for enoxaparin. Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting
2011
Conference Contribution - Published proceedings: Abstract
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011). Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity. Proceedings of the Twentieth Annual Meeting of the Population Approach Group in Europe. PAGE. Retrieved from http://www.page-meeting.org/?abstract=1967
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011). Identification and initial evaluation of a prototype clotting time test for enoxaparin. Proceedings of the Population Approach Group in Australia and New Zealand Meeting (PAGANZ). PAGANZ. Retrieved from http://www.paganz.org/default.asp?id=45&keuze=program
Conference Contribution - Verbal presentation and other Conference outputs
Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011, December). Identification and initial evaluation of a prototype clotting time test for enoxaparin. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), Australian Physiological Society (AuPS), High Blood Pressure Research Council of Australia (HBPRCA) Joint Meeting, Perth, Australia.
2010
Conference Contribution - Published proceedings: Abstract
Gulati, A., Faed, J., Isbister, G., & Duffull, S. B. (2010). Development and evaluation of a clotting time test for monitoring enoxaparin therapy. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/
2009
Journal - Research Article
Harkins, C., Hammond-Tooke, G., & Faed, J. (2009). Intravenous immunoglobulin therapy for neurological disorders. New Zealand Medical Journal, 122(1305). Retrieved from http://journal.nzma.org.nz/journal/122-1305/3850/content.pdf
Conference Contribution - Published proceedings: Abstract
Badami, K., Kyle, P. M., Faed, J. M., Russell, G. A., Warrington, S. C., & Wall, L. D. (2009). Haemolytic disease of the fetus and newborn due to Anti-RH17-treatment with ABO-mismatched, Rhnull & CMV-positive transfusions. Transfusion. 49(Suppl.), (pp. 205A-206A). [Abstract]
2007
Journal - Research Article
Dear, A., Brennan, S. O., Sheat, M. J., Faed, J. M., & George, P. M. (2007). Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain. Haematologica, 92, e111-e117. doi: 10.3324/haematol.11837
2002
Conference Contribution - Published proceedings: Abstract
Zacharias, M., Hodgson, B. F., & Faed, J. M. (2002). Bleeding in scoliosis surgery - a retrospective audit. New Zealand Orthopaedic Association Conference. 84(B), (pp. 272). Journal of Bone and Joint Surgery. [Abstract]
2001
Journal - Research Article
Ferguson, E. L., Morison, I. M., Faed, J. M., Parnell, W. R., McKenzie, J. E., Wilson, N. C., & Russell, D. G. (2001). Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: Is there a cause for concern? New Zealand Medical Journal, 114, 134-148.
2000
Journal - Research Article
Brennan, S. O., Fellowes, A. P., Faed, J. M., & George, P. M. (2000). Hypofibrinogenemia in an individual with two coding (γ82 Ala→Gly and β235 Pro→Leu) and two non-coding mutations. Blood, 95, 1709-1713.
Conference Contribution - Published proceedings: Abstract
Faed, J. M. (2000). Is a new approach needed to the female blood donor with low iron status? Vox Sanguinis. 78, (pp. P331). [Abstract]
Faed, J. M. (2000). A simple method for screening red cell and platelet units for bacteria. Vox Singuinis. 78. [Abstract]
1999
Authored Book - Research
Russell, D. G., Parnell, W. R., Wilson, N. C., Faed, J. M., Ferguson, E. L., Horwath, C. C., Herbison, G. P., Nye, E. R., Reid, P., Walker, R. J., Wilson, B. D., & Tukuitonga, C. (1999). NZ Food: NZ People. Key results of the 1997 National Nutrition Survey (LINZ® Activity & Health Research Unit). Wellington: Ministry of Health, 268p.
Journal - Research Article
Scrimshaw, B. J., Faed, J. M., Tate, W. P., & Yun, K. (1999). The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss. New Zealand Medical Journal, 112, 216-217.
Scrimshaw, B. J., Faed, J. M., Tate, W. P., & Yun, K. (1999). Rapid identification of a 1555 A to G mutation in human mitochronical DNA implicated in aminoglycoside-induced ototoxicity. Journal of Human Genetics, 44, 388-390.
Conference Contribution - Published proceedings: Abstract
Skeaff, C. M., Nye, E. R., Faed, J. M., Mann, J. I., McKenzie, J. D., Parnell, W. R., Wilson, N. C., & Russell, D. G. (1999). Cholesterol status of the New Zealand population: Should we be concerned? Pacific Partners in Nutrition, 2nd South-West Pacific Nutrition & Dietetic Conference. Auckland, NZ. [Abstract]
Ferguson, E. L., Faed, J. M., Morison, I. M., McKenzie, J. D., Parnell, W. R., Wilson, N. C., & Russell, D. G. (1999). Iron status in New Zealand: Is there a public health concern? Pacific Partners in Nutrition, 2nd South-West Pacific Nutrition & Dietetic Conference. Auckland. [Abstract]
1998
Conference Contribution - Published proceedings: Abstract
Faed, J. M., Tan, G. H., Shew, M., Gouldie, P. J., & Williams, S. L. (1998). Optimisation of conditions for cryoprecipitation of fibrinogen. Transfusion suppl. 38, (pp. 76S). [Abstract]
1997
Journal - Research Article
Burt, M. J., Upton, J. D., Morison, I. M., Chapman, B. A., Faed, J. M., & George, P. M. (1997). Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. New Zealand Medical Journal, 110(1056), 429-432.
Takeuchi, T., Soejima, H., Faed, J. M., & Yun, K. (1997). Efficient large-scale screening for the hemochromatosis susceptibility gene mutation. Blood, 90(7), 2848-2849.
Ridgeway, H. J., Brennan, S. O., Faed, J. M., & George, P. M. (1997). Fibrinogen Otago: A major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. British Journal of Haematology, 98(3), 632-639. doi: 10.1046/j.1365-2141.1997.2753090.x
Journal - Research Other
Soejima, H., Takeuchi, T., Gunn, J., Faed, J. M., & Yun, K. (1997). Rapid identification of a hemochromatosis susceptibility gene mutation. Trends in Genetics, Technical Tips Online, 2, 107-108. Retrieved from http://www.elsevier.com/locate/tto
Conference Contribution - Published proceedings: Full paper
Fitches, A., Hananeia, L., Faed, J. M., & Olds, R. J. (1997). Antithrombin locus genotype and plasma antithrombin activity. Thrombosis and Haemostasis. Supplement, (pp. 432). [Full Paper]
Conference Contribution - Published proceedings: Abstract
Faed, J. M. (1997). Particle release from blood donor packs: A new quality assurance test is needed. Transfusion suppl. 37, (pp. S145). [Abstract]
Faed, J. M. (1997). Successful management of pregnancy in a patient with severe dysfibrinogenaemia. Transfusion suppl. 38, (pp. 82). [Abstract]
1996
Conference Contribution - Published proceedings: Abstract
Ridgeway, H. J., Brennan, S. O., Faed, J. M., & George, P. M. (1996). Fibrinogen Otago: A new mutation causing chain truncation and severe hypofibrinogenaemia. Fibrinolysis, 10(Suppl. 4), (pp. 15-16). doi: 10.1016/S0268-9499(96)80802-2